Axelar (Drug Discovery) Overview

  • Year Founded
  • 2003

Year Founded

  • Status
  • Out of Business

  • Employees
  • 8

Employees

  • Latest Deal Type
  • Out of Business

Axelar (Drug Discovery) General Information

Description

Operator of a drug development company intended to develop targeted oral anti-cancer therapies. The company specializes in the research and development of anti-cancer treatments that focus on inhibitors of the insulin-like growth factor receptor and their applications in cancer, enabling the healthcare industry to facilitate cancer treatment at an affordable price.

Contact Information

Website
www.axelar.se
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2A, Solna
  • 171 65 Stockholm
  • Sweden
+46 08-446
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Karolinska Institutet Science Park
  • Fogdevreten 2A, Solna
  • 171 65 Stockholm
  • Sweden
+46 08-446

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Axelar (Drug Discovery) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
5. Out of Business 22-Oct-2021 Completed Out of Business
4. Secondary Transaction - Private 30-Mar-2015 Completed Generating Revenue
3. Later Stage VC 13-Feb-2013 Completed Generating Revenue
2. Later Stage VC 11-May-2011 $20M $20M Completed Generating Revenue
1. Early Stage VC 12-Jun-2008 Completed Generating Revenue
To view Axelar (Drug Discovery)’s complete valuation and funding history, request access »

Axelar (Drug Discovery) Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last
Financing
Details
Operator of a drug development company intended to develop targeted oral anti-cancer therapies. The company specializes
Drug Discovery
Stockholm, Sweden
8 As of 2015

Seongnam-si, South Korea
 
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Axelar (Drug Discovery) Competitors (1)

One of Axelar (Drug Discovery)’s competitors is Connext, a Venture Capital-Backed company based in Seongnam-si, South Korea.

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Connext Venture Capital-Backed Seongnam-si, South Korea
You’re viewing 1 of 1 competitors. Get the full list »

Axelar (Drug Discovery) Patents

Axelar (Drug Discovery) Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2019130194-A1 Novel drug products of picropodophyllin Inactive 29-Dec-2017
WO-2013132262-A1 Picropodophyllin derivatives Inactive 09-Mar-2012
WO-2013132263-A1 Picropodophyllin derivatives for use in therapy Inactive 09-Mar-2012
CA-2812926-A1 Picropodophyllin monohydrate or polymorph a in cancer therapy Inactive 08-Oct-2010
EP-2624828-A1 Picropodophyllin monohydrate or polymorph a in cancer therapy Inactive 08-Oct-2010 A61K31/365
To view Axelar (Drug Discovery)’s complete patent history, request access »

Axelar (Drug Discovery) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Axelar (Drug Discovery) FAQs

  • When was Axelar (Drug Discovery) founded?

    Axelar (Drug Discovery) was founded in 2003.

  • Where is Axelar (Drug Discovery) headquartered?

    Axelar (Drug Discovery) is headquartered in Stockholm, Sweden.

  • What is the size of Axelar (Drug Discovery)?

    Axelar (Drug Discovery) has 8 total employees.

  • What industry is Axelar (Drug Discovery) in?

    Axelar (Drug Discovery)’s primary industry is Drug Discovery.

  • Is Axelar (Drug Discovery) a private or public company?

    Axelar (Drug Discovery) is a Private company.

  • What is Axelar (Drug Discovery)’s current revenue?

    The current revenue for Axelar (Drug Discovery) is .

  • How much funding has Axelar (Drug Discovery) raised over time?

    Axelar (Drug Discovery) has raised $20M.

  • Who are Axelar (Drug Discovery)’s competitors?

    Connext is a competitor of Axelar (Drug Discovery).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process